| Code | 2842E | ||||||||||
| MA number | 58/0003/23-S | ||||||||||
| Product Form: | cps dur 30x2,5 mg/1,25 mg (blis.BOPA/Al/PVC laminát/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | BAUSCH HEALTH IRELAND LIMITED, Ireland | ||||||||||
| Therapeutic Class: | 58 - HYPOTENSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10b fixed combination application |
| MA issued: | 06.04.2023 |
| Validity: | 06.04.2028 |
| SPC: |
SPC_Ralbior_cps dur_03_2024.pdf
|
| PIL: |
PIL_Ralbior_cps dur_03_2024.pdf
|
| Safety feature | Yes |
| Data update: | 18.04.2023 |
